Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)

被引:109
作者
Biazar, Cyrus [1 ]
Sigges, Johanna [1 ]
Patsinakidis, Nikolaos [1 ]
Ruland, Vincent [1 ]
Amler, Susanne [2 ]
Bonsmann, Gisela [1 ]
Kuhn, Annegret [1 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
关键词
Autoimmune disease; Cutaneous lupus erythematosus; Europe; Database analysis; Questionnaire; REVISED CRITERIA; LIGHT ERUPTION; SKIN-LESIONS; PHOTOSENSITIVITY; MANIFESTATIONS; DISEASE; IMMUNOFLUORESCENCE; PHOTOPROVOCATION; PHOTOPROTECTION; CLASSIFICATION;
D O I
10.1016/j.autrev.2012.08.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0 +/- 15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and Sjogren's Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:444 / 454
页数:11
相关论文
共 51 条
  • [1] The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
    Albrecht, J
    Taylor, L
    Berlin, JA
    Dulay, S
    Ang, G
    Fakharzadeh, S
    Kantor, J
    Kim, E
    Militello, G
    McGinnis, K
    Richardson, S
    Treat, J
    Vittorio, C
    Van Voorhees, A
    Werth, VP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) : 889 - 894
  • [2] Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus
    Albrecht, J
    Berlin, JA
    Braverman, IM
    Callen, JP
    Costner, MI
    Dutz, J
    Fivenson, D
    Franks, AG
    Jorizzo, JL
    Lee, LA
    McCauliffe, DP
    Sontheimer, RD
    Werth, VP
    [J]. LUPUS, 2004, 13 (11) : 839 - 849
  • [3] Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
    Bein, D.
    Kuehn, E.
    Meuth, A. M.
    Amler, S.
    Haust, M.
    Nyberg, F.
    Sauerland, C.
    Luger, T. A.
    Bonsmann, G.
    Kuhn, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (06) : 652 - 659
  • [4] Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis
    Bizzaro, Nicola
    Villalta, Danilo
    Giavarina, Davide
    Tozzoli, Renato
    [J]. AUTOIMMUNITY REVIEWS, 2012, 12 (02) : 97 - 106
  • [5] The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience
    Cardinali, C
    Caproni, M
    Bernacchi, E
    Amato, L
    Fabbri, P
    [J]. LUPUS, 2000, 9 (06) : 417 - 423
  • [6] Cervera R, 2002, ANN MED INTERNE, V153, P530
  • [7] Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus
    Chan, Vera Sau-Fong
    Nie, Yin-Jie
    Shen, Nan
    Yan, Sheng
    Mok, Mo-Yin
    Lau, Chak-Sing
    [J]. AUTOIMMUNITY REVIEWS, 2012, 11 (12) : 890 - 897
  • [8] COHEN A S, 1971, Bulletin on the Rheumatic Diseases, V21, P643
  • [9] Costner MI, 2003, CUTANEOUS MANIFESTAT, P15
  • [10] Gilliam J N., 1977, Cont Educ Fam Phys, V6, P34